Company profile

Eikon

Eikon Therapeutics has raised $1.16 billion in total funding, including a $518 million Series B round on January 6, 2022, led by T. Rowe Price, CPP Investments, and EcoR1 Capital, valuing it at $3.1 billion. Founded in 2019 and based in Hayward, California, Eikon develops protein-tracking and measurement platforms for drug discovery using super-resolution microscopy and AI-driven analytics. With 11–50 employees, Eikon is transforming how researchers visualize protein behavior, aiming to accelerate breakthroughs in oncology, immunology, and therapeutic development.

Back to profiles

Quick facts

Total funding: $1.16 billion
Founded: 2019
Headquarters: Hayward, California, Eikon develops protein-tracking and measurement platforms for drug discovery using super-resolution microscopy and AI-driven analytics
Employees: 11 to 50

Reach buyers like Eikon on TexAu

TexAu helps go-to-market teams find, enrich, and reach companies that match this profile. Pick the path that fits how you work.

Find companies like Eikon
Build a list by industry, headcount, funding stage, or technographics. Get verified emails and direct dials.
Start a free workspace
Enrich your CRM with company data
Push funding, headcount, hiring signals, and tech stack into HubSpot, Salesforce, or a spreadsheet. Waterfall enrichment.
See how the waterfall works
Run it on a schedule
Refresh the list weekly, score new accounts as they land, and push the ones that fit to Smartlead, Instantly, Lemlist, HeyReach, or Apollo Sequences.
See how schedulers work

Reach buyers like Eikon.

The 14-day trial ships every feature, no card required.

Start free →